Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors
- 1 August 2000
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 81 (8) , 2077-2084
- https://doi.org/10.1099/0022-1317-81-8-2077
Abstract
Although adeno-associated virus (AAV)-2 has a broad tissue-host range and can transduce a wide variety of tissue types, some cells, such as erythro-megakaryoblastoid cells, are non-permissive and appear to lack the AAV-2 receptor. However, limited studies have been reported with the related dependovirus AAV-3. We have previously cloned this virus, characterized its genome and produced an infectious clone. In this study, the gene for green fluorescent protein (GFP) was inserted into AAV-2- and AAV-3-based plasmids and recombinant viruses were produced. These viruses were then used to transduce haematopoietic cells and the transduction efficiencies were compared. In contrast to recombinant (r) AAV-2, rAAV-3 successfully transduced erythroid and megakaryoblastoid cells, although rAAV-2 was superior in transduction of lymphocyte-derived cell lines. Recently, it was reported that heparan sulphate can act as a receptor of AAV-2. The infectivity of rAAV-2 and rAAV-3 was tested with mutant cell lines of Chinese hamster ovary cells that were defective for heparin or heparan sulphate expression on the cell surface. There was no correlation between the ability of rAAV-2 or rAAV-3 to infect cells and the cell surface expression of heparan sulphate and, although heparin blocked both rAAV-2 and rAAV-3 transduction, the ID50of rAAV-3 was higher than that of rAAV-2. In addition, virus-binding overlay assays indicated that AAV-2 and AAV-3 bound different membrane proteins. These results suggest not only that there are different cellular receptors for AAV-2 and AAV-3, but that rAAV-3 vectors may be preferred for transduction of some haematopoietic cell types.Keywords
This publication has 17 references indexed in Scilit:
- Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophiliaGene Therapy, 1998
- Nucleotide Sequencing and Generation of an Infectious Clone of Adeno-Associated Virus 3Virology, 1996
- Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infectionJournal of General Virology, 1996
- Adeno-Associated Virus Type 2 Binds to a 150-Kilodalton Cell Membrane GlycoproteinVirology, 1996
- Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood.The Journal of Experimental Medicine, 1994
- Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell line as demonstrated by in situ hybridizationJournal of General Virology, 1994
- Early and Late Gene Expression in UT-7 Cells Infected with B19 ParvovirusVirology, 1993
- Cell density regulates the number of cell surface receptors for fibroblast growth factorBiochemical and Biophysical Research Communications, 1989
- Tumor Formation Dependent on Proteoglycan BiosynthesisScience, 1988
- Animal cell mutants defective in glycosaminoglycan biosynthesis.Proceedings of the National Academy of Sciences, 1985